TMER2-i

N/A

Report date: 2025/02/21 16:20:28
NME

Base Information

Drug NameTMER2-i
Drug Alias NameCT-3021TMER2-i
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonistsAdenosine A2b receptor antagonists
TargetsAdenosine A1 receptorAdenosine A2a receptorAdenosine A2b receptor
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrossignal Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrossignal Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A